Symptomatic Intracranial Stenosis: Cerebrovascular Complications from Elective Stent Placement

Purpose: To retrospectively evaluate the cerebrovascular complications from elective stent placement for symptomatic intracranial stenosis and to explore preliminarily which factors are associated with complications.

Materials and Methods: Institutional ethics committee approval was obtained, with waiver of informed consent. Records were reviewed of 181 consecutive elective stent placement procedures in 169 patients (mean age, 51.8 years; 142 male and 27 female patients) with symptomatic intracranial stenosis of more than 50% diameter reduction. Complications were evaluated. Fisher exact or χ2 tests were used to assess statistical differences between rates for discrete variables. Stratification analysis was used to assess the significant relationship (P < .05) between a potential risk factor and a complication.

Results: Complications occurred in 20 patients (11.8%) of 169 patients: Ten patients (5.9%) had stroke (four patients had symptomatic intracranial hemorrhages [ICHs], and two of these patients died; six patients had ischemic strokes). Six patients had target-lesion thrombosis for which intrathrombus thrombolysis resulted in early complete patency without sequelae, two had asymptomatic ICHs, one had transient ischemic attack, and one had asymptomatic dissection. Perioperative noncompliance with antiplatelet therapy was found to be significantly associated with target-lesion thrombosis (two of eight patients [noncompliance] vs four of 161 patients [compliance], P = .027). Stratification analysis revealed a significant correlation between the use of double stents for a lesion and ICH (P = .005).

Conclusion: Cerebrovascular complications from elective stent placement for intracranial stenosis are diverse. The use of double stents for a lesion is an independent risk factor for ICH. Perioperative noncompliance with antiplatelet therapy is associated with a higher frequency of target-lesion thrombosis.

© RSNA, 2007


  • 1 Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541–1545. MedlineGoogle Scholar
  • 2 Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 2002;33:532–536. Crossref, MedlineGoogle Scholar
  • 3 Arenillas JF, Molina CA, Montaner J, Abilleira S, González-Sánchez MA, Álvarez-Sabin J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001;32:2898–2904. Crossref, MedlineGoogle Scholar
  • 4 Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389–1392. Crossref, MedlineGoogle Scholar
  • 5 Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–497. Crossref, MedlineGoogle Scholar
  • 6 Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–1316. Crossref, MedlineGoogle Scholar
  • 7 Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192–198. Crossref, MedlineGoogle Scholar
  • 8 Yokote H, Terada T, Ryujin K, et al. Percutaneous transluminal angioplasty of intracranial arteriosclerotic lesions. Neuroradiology 1998;40:590–596. Crossref, MedlineGoogle Scholar
  • 9 Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065–1069. Crossref, MedlineGoogle Scholar
  • 10 Connors JJ, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415–423. Crossref, MedlineGoogle Scholar
  • 11 Lee JH, Kwon SU, Lee JH, Suh DC, Kim JS. Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis 2003;15:90–97. Crossref, MedlineGoogle Scholar
  • 12 Yoon W, Seo JJ, Cho KH, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005;237:620–626. LinkGoogle Scholar
  • 13 Kim JK, Ahn JY, Lee BH, et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004;75:847–851. Crossref, MedlineGoogle Scholar
  • 14 Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375–1380. Crossref, MedlineGoogle Scholar
  • 15 de Rochemont Rdu M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of under-sized stents—initial experience. Radiology 2004;231:45–49. LinkGoogle Scholar
  • 16 SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388–1392. Crossref, MedlineGoogle Scholar
  • 17 Henkes H, Miloslavskil E, Lowens S, Reinartz J, Liebig T, Kühne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222–228. Crossref, MedlineGoogle Scholar
  • 18 Hartmann M, Jansen O. Angioplasty and stenting of intracranial stenosis. Curr Opin Neurol 2005;18:39–45. Crossref, MedlineGoogle Scholar
  • 19 Schumacher HC, Khaw AV, Meyers PM, Gupta R, Higashida RT. Intracranial angioplasty and stent placement for cerebral atherosclerosis. J Vasc Interv Radiol 2004;15(1 pt 2):S123–S132. Crossref, MedlineGoogle Scholar
  • 20 Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729–1735. Crossref, MedlineGoogle Scholar
  • 21 Furlan A, Higashida R, Wechsler L, et al. Intra-arterial pro-urokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. JAMA 1999;282:2003–2011. Crossref, MedlineGoogle Scholar
  • 22 Higashida RT, Meyers PM, Phatouros CC, Connors JJ 3rd, Barr JD, Sacks D. Reporting standards for carotid artery angioplasty and stent placement. Stroke 2004;35:e112–e134. Crossref, MedlineGoogle Scholar
  • 23 Morgenstern LB, Lisabeth LD, Mecozzi AC, et al. A population-based study of acute stroke and TIA diagnosis. Neurology 2004;62:895–900. Crossref, MedlineGoogle Scholar
  • 24 Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004;35:1925–1929. Crossref, MedlineGoogle Scholar
  • 25 Gan R, Sacco RL, Kargman DE, et al. Testing the validity of lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology 1997;48:1204–1211. Crossref, MedlineGoogle Scholar
  • 26 Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66(12):1868–1872. Crossref, MedlineGoogle Scholar
  • 27 Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion after carotid artery stenting. J Am Coll Cardiol 2004;43:1596–1601. Crossref, MedlineGoogle Scholar
  • 28 Dalman JE, Beenakkers IC, Moll FL, Leusink JA, Ackerstaff RG. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg 1999;18:222–227. Crossref, MedlineGoogle Scholar
  • 29 Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661–1668. MedlineGoogle Scholar
  • 30 Masuo O, Terada T, Walker G, Tsuura M, Nakai K, Itakura T. Patency of perforating arteries after stent placement? a study using an in vivo experimental atherosclerosis-induced model. AJNR Am J Neuroradiol 2005;26:543–548. MedlineGoogle Scholar

Article History

Published in print: 2007